336 related articles for article (PubMed ID: 9316840)
21. Role of nitric oxide and endothelin-1 in monocrotaline-induced pulmonary hypertension in rats.
Mathew R; Zeballos GA; Tun H; Gewitz MH
Cardiovasc Res; 1995 Nov; 30(5):739-46. PubMed ID: 8595621
[TBL] [Abstract][Full Text] [Related]
22. Contribution of endogenous endothelin-1 to the progression of cardiopulmonary alterations in rats with monocrotaline-induced pulmonary hypertension.
Miyauchi T; Yorikane R; Sakai S; Sakurai T; Okada M; Nishikibe M; Yano M; Yamaguchi I; Sugishita Y; Goto K
Circ Res; 1993 Nov; 73(5):887-97. PubMed ID: 8403258
[TBL] [Abstract][Full Text] [Related]
23. 2-Methoxyestradiol mediates the protective effects of estradiol in monocrotaline-induced pulmonary hypertension.
Tofovic SP; Zhang X; Jackson EK; Dacic S; Petrusevska G
Vascul Pharmacol; 2006 Dec; 45(6):358-67. PubMed ID: 16872912
[TBL] [Abstract][Full Text] [Related]
24. Roles of endothelin ETA and ETB receptors in the pathogenesis of monocrotaline-induced pulmonary hypertension.
Nishida M; Eshiro K; Okada Y; Takaoka M; Matsumura Y
J Cardiovasc Pharmacol; 2004 Aug; 44(2):187-91. PubMed ID: 15243299
[TBL] [Abstract][Full Text] [Related]
25. Effect of ET(A) receptor antagonist on pulmonary hypertension and vascular reactivity in rats with congestive heart failure.
Lucas M; Jasmin JF; Dupuis J
Pulm Pharmacol Ther; 2001; 14(4):307-14. PubMed ID: 11440559
[TBL] [Abstract][Full Text] [Related]
26. Effects of ET-A receptor blockade on eNOS gene expression in chronic hypoxic rat lungs.
Blumberg FC; Wolf K; Arzt M; Lorenz C; Riegger GA; Pfeifer M
J Appl Physiol (1985); 2003 Feb; 94(2):446-52. PubMed ID: 12391096
[TBL] [Abstract][Full Text] [Related]
27. Angiotensin-converting enzyme inhibition and endothelin antagonism for endothelial dysfunction in heart failure: mono-or combination therapy.
Bauersachs J; Fraccarollo D; Schäfer A; Ertl G
J Cardiovasc Pharmacol; 2002 Oct; 40(4):594-600. PubMed ID: 12352322
[TBL] [Abstract][Full Text] [Related]
28. Oral sildenafil prevents and reverses the development of pulmonary hypertension in monocrotaline-treated rats.
Liu H; Liu ZY; Guan Q
Interact Cardiovasc Thorac Surg; 2007 Oct; 6(5):608-13. PubMed ID: 17670742
[TBL] [Abstract][Full Text] [Related]
29. Effects of selective and unselective endothelin-receptor antagonists on prostacyclin synthase gene expression in experimental pulmonary hypertension.
Schroll S; Arzt M; Sebah D; Stoelcker B; Luchner A; Budweiser S; Blumberg FC; Pfeifer M
Scand J Clin Lab Invest; 2008; 68(4):270-6. PubMed ID: 18612919
[TBL] [Abstract][Full Text] [Related]
30. CPU0213, a non-selective ETA/ETB receptor antagonist, improves pulmonary arteriolar remodeling of monocrotaline-induced pulmonary hypertension in rats.
Cui B; Cheng YS; Dai DZ; Li N; Zhang TT; Dai Y
Clin Exp Pharmacol Physiol; 2009 Feb; 36(2):169-75. PubMed ID: 18986320
[TBL] [Abstract][Full Text] [Related]
31. Effect of chronic ETA-selective endothelin receptor antagonism on blood pressure in experimental and genetic hypertension in rats.
Schiffrin EL; Turgeon A; Deng LY
Br J Pharmacol; 1997 Jul; 121(5):935-40. PubMed ID: 9222550
[TBL] [Abstract][Full Text] [Related]
32. The HMG-CoA reductase inhibitor, pravastatin, prevents the development of monocrotaline-induced pulmonary hypertension in the rat through reduction of endothelial cell apoptosis and overexpression of eNOS.
Guerard P; Rakotoniaina Z; Goirand F; Rochette L; Dumas M; Lirussi F; Bardou M
Naunyn Schmiedebergs Arch Pharmacol; 2006 Sep; 373(6):401-14. PubMed ID: 16896805
[TBL] [Abstract][Full Text] [Related]
33. Angiotensin II and monocrotaline-induced pulmonary hypertension: effect of losartan (DuP 753), a nonpeptide angiotensin type 1 receptor antagonist.
Cassis LA; Rippetoe PE; Soltis EE; Painter DJ; Fitz R; Gillespie MN
J Pharmacol Exp Ther; 1992 Sep; 262(3):1168-72. PubMed ID: 1527721
[TBL] [Abstract][Full Text] [Related]
34. Enhanced gene expression of renin-angiotensin system, TGF-beta1, endothelin-1 and nitric oxide synthase in right-ventricular hypertrophy.
Park HK; Park SJ; Kim CS; Paek YW; Lee JU; Lee WJ
Pharmacol Res; 2001 Mar; 43(3):265-73. PubMed ID: 11401419
[TBL] [Abstract][Full Text] [Related]
35. Estradiol metabolites attenuate monocrotaline-induced pulmonary hypertension in rats.
Tofovic SP; Salah EM; Mady HH; Jackson EK; Melhem MF
J Cardiovasc Pharmacol; 2005 Oct; 46(4):430-7. PubMed ID: 16160593
[TBL] [Abstract][Full Text] [Related]
36. Endothelin-1 is elevated in monocrotaline pulmonary hypertension.
Frasch HF; Marshall C; Marshall BE
Am J Physiol; 1999 Feb; 276(2):L304-10. PubMed ID: 9950893
[TBL] [Abstract][Full Text] [Related]
37. Preventive treatment with atorvastatin ameliorates endothelial dysfunction of small pulmonary arteries in monocrotaline-induced pulmonary hypertensive rats.
Lin Z; Jiang Z; Huang X; Cai X; Wang H; Xie L
Clin Exp Hypertens; 2017; 39(6):495-501. PubMed ID: 28628347
[TBL] [Abstract][Full Text] [Related]
38. Endothelin A receptor blockade causes adverse left ventricular remodeling but improves pulmonary artery pressure after infarction in the rat.
Nguyen QT; Cernacek P; Calderoni A; Stewart DJ; Picard P; Sirois P; White M; Rouleau JL
Circulation; 1998 Nov; 98(21):2323-30. PubMed ID: 9826321
[TBL] [Abstract][Full Text] [Related]
39. LU135252, an endothelin(A) receptor antagonist did not prevent pulmonary vascular remodelling or lung fibrosis in a rat model of myocardial infarction.
Nguyen QT; Colombo F; Rouleau JL; Dupuis J; Calderone A
Br J Pharmacol; 2000 Aug; 130(7):1525-30. PubMed ID: 10928953
[TBL] [Abstract][Full Text] [Related]
40. [Role of leukotriene B4 in monocrotaline-induced pulmonary hypertension].
Tabata T; Ono S; Song C; Noda M; Suzuki S; Tanita T; Fujimura S
Nihon Kyobu Shikkan Gakkai Zasshi; 1997 Feb; 35(2):160-6. PubMed ID: 9103852
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
